May 2023 updates to the website

The website has now been updated following the May meeting of the LSCMMG

The following guidelines have been added/updated:
MHRA Alert: JAK inhibitors
Sodium Zirconium Cyclosilicate – Evidence Review – no RAG change
Camouflaging Products – Update
Sevelamer generic

The following Items will be updated and added to the website following the next Pharmacy and Medicines Policy Task and Finish Group Meeting:

Trifarotene (Aklief®) 50 microgram/g cream for the cutaneous treatment of acne vulgaris of the face and/or the trunk in patients from 12 years of age and older, when many comedones, papules and pustules are present
TheraBite® Jaw Rehabilitation Device for the treatment of trismus and mandibular
Budesonide M/R 9mg tablets (Cortiment MMX) RAG status change proposal
Estradiol (as estradiol hemihydrate) and progesterone 1mg/100mg Soft Capsules (Bijuve®) For continuous combined hormone replacement therapy (HRT) for oestrogen deficiency symptoms in postmenopausal women with intact uterus and with at least 12 months since last menses
IQoro for treatment of hiatus hernia and for treatment of stroke related dysphagia.